A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis

被引:4
|
作者
Yamazaki, Haruhiko [1 ]
Iwasaki, Hiroyuki [1 ]
Yamashita, Toshinari [1 ]
Yoshida, Tatsuya [1 ]
Suganuma, Nobuyasu [1 ]
Yamanaka, Takashi [1 ]
Masudo, Katsuhiko [2 ]
Nakayama, Hirotaka [3 ]
Kohagura, Kaori [3 ]
Rino, Yasushi [3 ]
Masuda, Munetaka [3 ]
机构
[1] Kanagawa Canc Ctr, Dept Breast & Endocrine Surg, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Med Ctr, Dept Breast andThyroid Surg, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Sch Med, Dept Surg, Yokohama, Kanagawa, Japan
关键词
D O I
10.1155/2018/7875929
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 63-year-old man was diagnosed with multiple lung metastases from anaplastic thyroid cancer and received lenvatinib. Followup computed tomography on day 34 of lenvatinib treatment showed pneumothorax. The pneumothorax was temporarily improved with chest drainage. However, pleurodesis was performed to treat a relapse of the pneumothorax. Pneumothorax during chemotherapy for a malignant tumor is considered a relatively rare complication. This case is the first documentation that pneumothorax may develop during lenvatinib treatment. The possible development of pneumothorax should be considered when lenvatinib is used in patients with lung metastasis.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
    Ferrari, Silvia Martina
    Bocci, Guido
    Di Desidero, Teresa
    Elia, Giusy
    Ruffilli, Ilaria
    Ragusa, Francesca
    Orlandi, Paola
    Paparo, Sabrina Rosaria
    Patrizio, Armando
    Piaggi, Simona
    La Motta, Concettina
    Ulisse, Salvatore
    Baldini, Enke
    Materazzi, Gabriele
    Miccoli, Paolo
    Antonelli, Alessandro
    Fallahi, Poupak
    ONCOLOGY REPORTS, 2018, 39 (05) : 2225 - 2234
  • [32] Efficacy and safety of lenvatinib in 124 Japanese patients with anaplastic thyroid cancer
    Takahashi, Shunji
    Tahara, Makoto
    Ito, Koichi
    Tori, Masayuki
    Sakata, Yukinori
    Ishii, Mika
    Yoishida, Akira
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Thyroid metastasis of a lung cancer and abnormal thyroid function - a case report
    Wirtz, G.
    Quoix, E.
    Grunenberger, F.
    Massard, G.
    Mennecier, B.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2009, 65 (01) : 27 - 31
  • [34] Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer
    Yokota, Tomoya
    Hamauchi, Satoshi
    Kawakami, Takeshi
    Fushiki, Kunihiro
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (04) : 361 - 368
  • [35] Rapid pleural effusion after discontinuation of lenvatinib in a patient with pleural metastasis from thyroid cancer
    Uchida, Taisuke
    Yamaguchi, Hideki
    Nagamine, Kazuhiro
    Yonekawa, Tadato
    Nakamura, Eriko
    Shibata, Nobuhiro
    Kawano, Fumiaki
    Asada, Yujiro
    Nakazato, Masamitsu
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2019,
  • [36] Three Cases of Anaplastic Thyroid Carcinoma Transformation and Leukocytosis during Lenvatinib Treatment
    Iwasaki, Hiroyuki
    Toda, Soji
    Murayama, Daisuke
    Takahashi, Hiroyuki
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [37] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Mijin Kim
    Jonghwa Ahn
    Dong Eun Song
    Jee Hee Yoon
    Ho-Cheol Kang
    Dong Jun Lim
    Won Gu Kim
    Tae Yong Kim
    Won Bae Kim
    Young Kee Shong
    Min Ji Jeon
    Bo Hyun Kim
    Endocrine, 2021, 71 : 427 - 433
  • [38] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Kim, Mijin
    Ahn, Jonghwa
    Song, Dong Eun
    Yoon, Jee Hee
    Kang, Ho-Cheol
    Lim, Dong Jun
    Kim, Won Gu
    Kim, Tae Yong
    Kim, Won Bae
    Shong, Young Kee
    Jeon, Min Ji
    Kim, Bo Hyun
    ENDOCRINE, 2021, 71 (02) : 427 - 433
  • [39] Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview
    Sparano, Clotilde
    Godbert, Yann
    Attard, Marie
    Do Cao, Christine
    Zerdoud, Slimane
    Roudaut, Nathalie
    Joly, Charlotte
    Berdelou, Amandine
    Hadoux, Julien
    Lamartina, Livia
    Schlumberger, Martin
    Leboulleux, Sophie
    ENDOCRINE-RELATED CANCER, 2021, 28 (01) : 15 - 26
  • [40] Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)
    Higashiyama, Takuya
    Sugino, Kiminori
    Hara, Hisato
    Ito, Ken-Ichi
    Nakashima, Noriaki
    Onoda, Naoyoshi
    Tori, Masayuki
    Katoh, Hiroshi
    Kiyota, Naomi
    Ota, Ichiro
    Suganuma, Nobuyasu
    Hibi, Yatsuka
    Nemoto, Toshimitsu
    Takahashi, Shunji
    Yane, Katsunari
    Ioji, Tetsuya
    Kojima, Shinsuke
    Kaneda, Hideaki
    Sugitani, Iwao
    Tahara, Makoto
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : 210 - 218